Moreover, the prevention group exhibited further suppression of the expression of inflammatory factors through the inhibition of the NF-κB pathway, which is highly relevant to autoimmunity and has been reported to influence the inflammatory mediators of RA; this effect was not observed in the treatment group (Figure 4F,G). This evidence concerns the gene NFKB1 and rheumatoid arthritis.